Status:

COMPLETED

CRESTOR Athero Imaging Head to Head IVUS Study

Lead Sponsor:

AstraZeneca

Collaborating Sponsors:

The Cleveland Clinic

Conditions:

Coronary Atherosclerosis

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

A 104-week, randomized, double-blind, parallel group, multi-center Phase IIIb study comparing the effects of treatment with rosuvastatin 40 mg or atorvastatin 80 mg on atherosclerotic disease burden a...

Eligibility Criteria

Inclusion

  • Clinical indication for coronary angiography
  • Angiographic evidence of Coronary Artery Disease (CAD), as defined by at least 1 lesion in a native coronary artery that has \>20% reduction in lumen diameter by visual estimation
  • Left main coronary artery must have \<=50% reduction in lumen diameter by visual estimation
  • LDL-C \>100 mg/dL (2.6 mmol/L) for patients with no statin therapy in the past 4 weeks; LDL-C \>80mg/dL (2.08mmol/L) for patients on therapy in the past 4 weeks

Exclusion

  • Use of certain lipid-lowering medication for more than 3 months within the previous 12 months. Longer periods of treatment are not permitted because of the potential effects of such therapy on coronary atherosclerosis.
  • Patients who have symptoms consistent with moderate or greater severity of Congestive Heart Failure (CHF).
  • Clinically significant heart disease which, in the opinion of the Principal Investigator (or designee), is likely to require coronary bypass surgery, cardiac transplantation, surgical repair and/or replacement during the course of the study

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

2333 Patients enrolled

Trial Details

Trial ID

NCT00620542

Start Date

January 1 2008

End Date

June 1 2011

Last Update

July 16 2012

Active Locations (195)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 49 (195 locations)

1

Research Site

Huntsville, Alabama, United States

2

Research Site

Los Angeles, California, United States

3

Research Site

Mountain View, California, United States

4

Research Site

Sacramento, California, United States